Trials / Completed
CompletedNCT01264575
ED50 and ED95 of Intrathecal Bupivacaine With or Without Epinephrine for Total Knee Replacement Arthroplasty
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 162 (actual)
- Sponsor
- Seoul Medical Center · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This prospective randomized double-blind dose-response study is aimed to investigate the ED50 and ED95 of intrathecal bupivacaine with or without epinephrine 100 mcg for total knee replacement arthroplasty.
Detailed description
Patients undergoing total knee replacement arthroplasty are randomly assigned to six bupivacaine dose group (6, 7, 8, 9, 10, 11 mg). Combined spinal-epidural anesthesia would be performed. The dose would be considered as successful if no epidural supplement was required during surgery. A probit analysis will be performed to calculate the ED50 and ED95 of intrathecal bupivacaine with or without epinephrine for total knee replacement arthroplasty. After these measurements, ED50 and ED95 of bupivacaine with epinephrine would be compared with those without epinephrine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | intrathecal bupivacaine 6 mg with 100 mcg of epinephrine | intrathecal bupivacaine 6 mg with 100 mcg of epinephrine |
| DRUG | intrathecal bupivacaine 7 mg with 100 mcg of epinephrine | intrathecal bupivacaine 7 mg with 100 mcg of epinephrine |
| DRUG | intrathecal bupivacaine 8 mg with 100 mcg of epinephrine | intrathecal bupivacaine 8 mg with 100 mcg of epinephrine |
| DRUG | intrathecal bupivacaine 9 mg with 100 mcg of epinephrine | intrathecal bupivacaine 9 mg with 100 mcg of epinephrine |
| DRUG | intrathecal bupivacaine 10 mg with 100 mcg of epinephrine | intrathecal bupivacaine 10 mg with 100 mcg of epinephrine |
| DRUG | intrathecal bupivacaine 11 mg with epinephrine 100 mcg | intrathecal bupivacaine 11 mg with epinephrine 100 mcg |
| DRUG | intrathecal bupivacaine 6 mg with 200 mcg of epinephrine | intrathecal bupivacaine 6 mg with 200 mcg of epinephrine |
| DRUG | intrathecal bupivacaine 7 mg with 200 mcg of epinephrine | intrathecal bupivacaine 7 mg with 200 mcg of epinephrine |
| DRUG | intrathecal bupivacaine 8 mg with 200 mcg of epinephrine | intrathecal bupivacaine 8 mg with 200 mcg of epinephrine |
| DRUG | intrathecal bupivacaine 9 mg with 200 mcg of epinephrine | intrathecal bupivacaine 9 mg with 200 mcg of epinephrine |
| DRUG | intrathecal bupivacaine 10 mg with 200 mcg of epinephrine | intrathecal bupivacaine 10 mg with 200 mcg of epinephrine |
| DRUG | intrathecal bupivacaine 11 mg with 200 mcg of epinephrine | intrathecal bupivacaine 11 mg with 200 mcg of epinephrine |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2010-12-22
- Last updated
- 2012-01-31
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01264575. Inclusion in this directory is not an endorsement.